Literature DB >> 29242049

Rational library design by functional CDR resampling.

Qi Zhao1, Diane Buhr2, Courtney Gunter2, Jenny Frenette2, Mary Ferguson2, Eric Sanford2, Erika Holland2, Chitra Rajagopal2, Melissa Batonick2, Margaret M Kiss2, Michael P Weiner2.   

Abstract

Successful antibody discovery relies on diversified libraries, where two aspects are implied, namely the absolute number of unique clones and the percentage of functional clones. Instead of pursuing the absolute quantity thresholded by current display technology, we have sought to maximize the effective diversity by improving functional clone percentage. With the combined effort of bioinformatics, structural biology, molecular immunology and phage display technology, we devised a bioinformatic pipeline to construct and validate libraries via combinatorial assembly of sequences from a database of experimentally validated antibodies. Furthermore, we showed that the libraries constructed as such yielded a significantly increased success rate against different antigen types and generated over 20-fold more unique hits per targets compared with libraries based on traditional degenerate nucleotide methods. Our study indicated that predefined CDR sequences with optimized CDR-framework compatibility could be a productive direction of functional library construction for in vitro antibody development.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 29242049      PMCID: PMC5995609          DOI: 10.1016/j.nbt.2017.12.005

Source DB:  PubMed          Journal:  N Biotechnol        ISSN: 1871-6784            Impact factor:   5.079


  25 in total

1.  Phage-displayed antibody libraries of synthetic heavy chain complementarity determining regions.

Authors:  Sachdev S Sidhu; Bing Li; Yvonne Chen; Frederic A Fellouse; Charles Eigenbrot; Germaine Fuh
Journal:  J Mol Biol       Date:  2004-04-23       Impact factor: 5.469

2.  Crystal structure of single-domain VL of an anti-DNA binding antibody 3D8 scFv and its active site revealed by complex structures of a small molecule and metals.

Authors:  Suk-Youl Park; Woo-Ram Lee; Suk-Chan Lee; Myung-Hee Kwon; Yong-Sung Kim; Jeong-Sun Kim
Journal:  Proteins       Date:  2008-06

3.  Directed evolution, phage display and combination of evolved mutants: a strategy to recover the neutralization properties of the scFv version of BCF2 a neutralizing monoclonal antibody specific to scorpion toxin Cn2.

Authors:  V R Juárez-González; L Riaño-Umbarila; V Quintero-Hernández; T Olamendi-Portugal; M Ortiz-León; E Ortíz; L D Possani; B Becerril
Journal:  J Mol Biol       Date:  2005-01-16       Impact factor: 5.469

4.  Construction of a scFv Library with Synthetic, Non-combinatorial CDR Diversity.

Authors:  Xuelian Bai; Hyunbo Shim
Journal:  Methods Mol Biol       Date:  2017

5.  Canonical structures for the hypervariable regions of immunoglobulins.

Authors:  C Chothia; A M Lesk
Journal:  J Mol Biol       Date:  1987-08-20       Impact factor: 5.469

6.  A strategy for the generation of specific human antibodies by directed evolution and phage display. An example of a single-chain antibody fragment that neutralizes a major component of scorpion venom.

Authors:  Lidia Riaño-Umbarila; Victor Rivelino Juárez-González; Timoteo Olamendi-Portugal; Mauricio Ortíz-León; Lourival Domingos Possani; Baltazar Becerril
Journal:  FEBS J       Date:  2005-05       Impact factor: 5.542

7.  Biopython: freely available Python tools for computational molecular biology and bioinformatics.

Authors:  Peter J A Cock; Tiago Antao; Jeffrey T Chang; Brad A Chapman; Cymon J Cox; Andrew Dalke; Iddo Friedberg; Thomas Hamelryck; Frank Kauff; Bartek Wilczynski; Michiel J L de Hoon
Journal:  Bioinformatics       Date:  2009-03-20       Impact factor: 6.937

8.  Employing in vitro directed molecular evolution for the selection of α-amylase variant inhibitors with activity toward cotton boll weevil enzyme.

Authors:  Maria Cristina Mattar da Silva; Rafael Perseghini Del Sarto; Wagner Alexandre Lucena; Daniel John Rigden; Fabíola Rodrigues Teixeira; Caroline de Andrade Bezerra; Erika Valéria Saliba Albuquerque; Maria Fatima Grossi-de-Sa
Journal:  J Biotechnol       Date:  2013-07-24       Impact factor: 3.307

9.  Thermodynamically stable aggregation-resistant antibody domains through directed evolution.

Authors:  Kristoffer Famm; Lars Hansen; Daniel Christ; Greg Winter
Journal:  J Mol Biol       Date:  2007-11-04       Impact factor: 5.469

10.  Bio.Phylo: a unified toolkit for processing, analyzing and visualizing phylogenetic trees in Biopython.

Authors:  Eric Talevich; Brandon M Invergo; Peter J A Cock; Brad A Chapman
Journal:  BMC Bioinformatics       Date:  2012-08-21       Impact factor: 3.169

View more
  4 in total

1.  Derivation of splice junction-specific antibodies using a unique hapten targeting strategy and directed evolution.

Authors:  Emily P Fuller; Rachel J O'Neill; Michael P Weiner
Journal:  N Biotechnol       Date:  2022-06-22       Impact factor: 6.490

Review 2.  Current advances in biopharmaceutical informatics: guidelines, impact and challenges in the computational developability assessment of antibody therapeutics.

Authors:  Rahul Khetan; Robin Curtis; Charlotte M Deane; Johannes Thorling Hadsund; Uddipan Kar; Konrad Krawczyk; Daisuke Kuroda; Sarah A Robinson; Pietro Sormanni; Kouhei Tsumoto; Jim Warwicker; Andrew C R Martin
Journal:  MAbs       Date:  2022 Jan-Dec       Impact factor: 5.857

Review 3.  Advances in the Production and Batch Reformatting of Phage Antibody Libraries.

Authors:  Rose H Reader; Robert G Workman; Ben C Maddison; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2019-11       Impact factor: 2.695

4.  A Simple Whole-Plasmid PCR Method to Construct High-Diversity Synthetic Phage Display Libraries.

Authors:  Maria T Tsoumpeli; Alison Gray; Aimee L Parsons; Anastasios Spiliotopoulos; Jonathan P Owen; Keith Bishop; Ben C Maddison; Kevin C Gough
Journal:  Mol Biotechnol       Date:  2022-02-02       Impact factor: 2.860

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.